Tresiba (Novo Nordisk)
(https://tresiba.com) 📸 Data Snapshot: June 20, 2026
Identity & Authority — The Lens
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Identity & Authority
Expert verifiability & Schema depth.
14
Impact Weight: 15 / 100
93% Reputation
Authority is robustly supported by the schema_json, which correctly identifies the page as a MedicalWebPage with Drug and MedicalCondition properties. The manufacturer, Novo Nordisk, is clearly identified with links to its affordability programs at NovoCare.com. No individual experts are named, but the authority is deferred to the FDA and healthcare providers, which is standard and credible for this industry.
There is no disconnect between marketing tone and clinical demonstration. Claims of around-the-clock management are backed by technical descriptions of how the insulin releases slow and steady from its molecular chain. The site does not over-promise; it balances every efficacy claim with a corresponding safety warning as required by law.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"audience": "Patient",
"specialty": "diabetes",
"url": "https://www.tresiba.com/",
"headline": "Find your reason for managing your blood sugar with Tresiba®, a once-daily long-acting insulin",
"description": "Tresiba® (insulin degludec) is a long-acting insulin taken once a day that works the way your body's insulin does to help control your blood sugar.",
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"item": {
"@id": "https://www.tresiba.com/",
"name": "Homepage"
}
}
]
},
"about": [
{
"@type": "MedicalCondition",
"name": [
"diabetes"
],
"alternateName": [
"type 1 diabetes",
"type 2 diabetes"
]
},
{
"@type": "MedicalTherapy",
"guideline": [
"Prescription Tresiba® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes"
],
"contraindication": [
"an episode of low blood sugar (hypoglycemia)",
"allergy to Tresiba® or any of the ingredients in Tresiba®"
],
"warning": [
"Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them."
],
"recognizingAuthority": {
"@type": "Organization",
"name": "U.S. Food and Drug Administration",
"alternateName": "FDA",
"url": "https://www.fda.gov/"
}
},
{
"@type": "Drug",
"Name": "Tresiba®",
"nonProprietaryName": "insulin degludec",
"prescriptionStatus": "Available by prescription",
"prescribingInfo": "https://www.novo-pi.com/tresiba.pdf",
"activeIngredient": "insulin degludec",
"alternateName": [
"Tresiba® (insulin aspart) injection 100 Units/mL, 200 Units/mL"
],
"dosageForm": "injection",
"administrationRoute": "injection",
"doseSchedule": [
{
"@type": "DoseSchedule",
"frequency": "once-daily",
"doseUnit": "Units/mL",
"doseValue": [
"100",
"200"
],
"targetPopulation": [
"adults and children who are 1 year of age and older with diabetes"
]
}
],
"offers": {
"@type": "Offer",
"price": "0",
"priceCurrency": "USD",
"url": "https://www.tresiba.com/"
},
"image": {
"@type": "ImageObject",
"name": "Tresiba® (insulin degludec injection) 100 Units/mL, 200 Units/mL logo",
"contentUrl": "https://www.tresiba.com/content/dam/diabetes/brand/insulin/tresiba/illustrations/Tresiba_U200-U100_Logo_KO.svg"
},
"manufacturer": {
"@type": "Organization",
"name": "Novo Nordisk",
"logo": "https://www.tresiba.com/content/dam/diabetes/brand/insulin/general/novo-nordisk-logo_ko.svg"
}
}
],
"maincontentofpage": [
{
"@type": "WebPageElement",
"headline": "Find your reason for managing your blood sugar with Tresiba®, a once-daily long-acting insulin",
"text": "Managing diabetes can be a struggle, but everyone has a reason to stay motivated. Tresiba® is a long-acting insulin that manages blood sugar for 24 hours for powerful A1C reduction in patients one year of age or older with diabetes.",
"potentialAction": {
"@type": "Action",
"name": "New to insulin?",
"target": "https://www.tresiba.com/get-to-know-tresiba/new-to-insulin.html"
}
},
{
"@type": "WebPageElement",
"headline": "Save on your Tresiba® prescription",
"text": "With the Tresiba® Savings Card, you can save on your prescription, if eligible.",
"potentialAction": {
"@type": "Action",
"name": "Learn more",
"target": "https://www.tresiba.com/savings.html"
}
},
{
"@type": "WebPageElement",
"headline": "Works like the body’s insulin",
"text": "Tresiba® is a long-acting insulin that releases slow and steady, and works the way the body’s insulin does.",
"potentialAction": {
"@type": "Action",
"name": "See how it works",
"target": "https://www.tresiba.com/get-to-know-tresiba/about-tresiba.html"
}
},
{
"@type": "WebPageElement",
"headline": "Starting Tresiba®?",
"text": "Get to know your Tresiba® FlexTouch® pen by watching a step-by-step video.",
"potentialAction": {
"@type": "Action",
"name": "Watch now",
"target": "https://www.tresiba.com/support-and-resources/videos-and-resources.html"
}
}
]
}
/savings.html
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"audience": "Patient",
"specialty": "diabetes",
"url": "https://www.tresiba.com/savings.html",
"headline": "Tresiba® savings and affordability",
"description": "Tresiba® (insulin degludec) is covered by most major health plans. Find out if you are eligible for a Tresiba® savings card. Read important safety and prescribing info on this page.",
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"item": {
"@id": "https://www.tresiba.com/",
"name": "Homepage"
}
},
{
"@type": "ListItem",
"position": 2,
"item": {
"@id": "https://www.tresiba.com/savings.html",
"name": "Savings"
}
}
]
},
"about": [
{
"@type": "MedicalCondition",
"name": [
"diabetes"
],
"alternateName": [
"type 1 diabetes",
"type 2 diabetes"
]
},
{
"@type": "MedicalTherapy",
"guideline": [
"Prescription Tresiba® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes"
],
"contraindication": [
"an episode of low blood sugar (hypoglycemia)",
"allergy to Tresiba® or any of the ingredients in Tresiba®"
],
"warning": [
"Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them."
],
"recognizingAuthority": {
"@type": "Organization",
"name": "U.S. Food and Drug Administration",
"alternateName": "FDA",
"url": "https://www.fda.gov/"
}
},
{
"@type": "Drug",
"Name": "Tresiba®",
"nonProprietaryName": "insulin degludec",
"activeIngredient": "insulin degludec",
"alternateName": [
"Tresiba® (insulin aspart) injection 100 Units/mL, 200 Units/mL"
],
"prescriptionStatus": "Available by prescription",
"prescribingInfo": "https://www.novo-pi.com/tresiba.pdf",
"dosageForm": "injection",
"administrationRoute": "injection",
"doseSchedule": [
{
"@type": "DoseSchedule",
"frequency": "once-daily",
"doseUnit": "Units/mL",
"doseValue": [
"100",
"200"
],
"targetPopulation": [
"adults and children who are 1 year of age and older with diabetes"
]
}
],
"offers": {
"@type": "Offer",
"price": "0",
"priceCurrency": "USD",
"url": "https://www.tresiba.com/savings.html"
},
"image": {
"@type": "ImageObject",
"name": "Tresiba® (insulin degludec injection) 100 Units/mL, 200 Units/mL logo",
"contentUrl": "https://www.tresiba.com/content/dam/diabetes/brand/insulin/tresiba/illustrations/Tresiba_U200-U100_Logo_KO.svg"
},
"manufacturer": {
"@type": "Organization",
"name": "Novo Nordisk",
"logo": "https://www.tresiba.com/content/dam/diabetes/brand/insulin/general/novo-nordisk-logo_ko.svg"
}
}
],
"maincontentofpage": [
{
"@type": "WebPageElement",
"headline": "Is Tresiba® Covered by My Insurance? ",
"text": "Tresiba® is covered by most major health plans, including Medicare and Medicaid.a Enter your information to check your health insurance benefits and find out how much you'll pay for Tresiba®.",
"potentialAction": {
"@type": "Action",
"name": "Learn more",
"target": "https://www.novocare.com/diabetes/products/tresiba/check-coverage.html"
}
},
{
"@type": "WebPageElement",
"headline": "Do you have commercial or private/employer-based insurance?",
"text": [
"If you have private or commercial insurance, such as insurance you receive through an employer or purchase yourself, you can pay as little as $35 or no more than $99 per prescription with the Tresiba® Savings Offer. Eligibility and other restrictions apply."
],
"potentialAction": {
"@type": "Action",
"name": "Start saving",
"target": "https://www.novocare.com/diabetes/products/tresiba/savings-offer.html?src=100001848"
}
},
{
"@type": "WebPageElement",
"headline": "Do you have Medicare?",
"text": [
"Do you have Medicare?"
],
"potentialAction": {
"@type": "Action",
"name": "Check your cost",
"target": "https://www.novocare.com/diabetes/products/tresiba/check-coverage.html"
}
},
{
"@type": "WebPageElement",
"headline": "Are you uninsured?",
"text": [
"TMyInsulinRx™",
"With this savings program, you may be eligible to pay $35 for a monthly supply of any combination of Novo Nordisk insulin products, up to 3 vials or 2 packs of pens (up to 35 mL). Offer is available each month during a calendar year. This cost does not apply to any insurance deductible you may have. Eligibility and restrictions apply."
],
"potentialAction": {
"@type": "Action",
"name": "View this offer",
"target": "https://www.novocare.com/diabetes/help-with-costs/help-with-insulin-costs/myinsulinrx.html"
}
},
{
"@type": "WebPageElement",
"headline": "Find Help With Insulin Costs",
"text": [
"If you are struggling to pay for your insulin, Novo Nordisk has affordability programs for every insurance situation in order to provide support for those who need help. "
],
"potentialAction": {
"@type": "Action",
"name": "View this offer",
"target": "https://www.novocare.com/diabetes/help-with-costs/help-with-insulin-costs.html"
}
}
]
}
/get-to-know-tresiba/about-tresiba.html — no schema detected (entity gap)
/support-and-resources/videos-and-resources.html
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"audience": "Patient",
"specialty": "diabetes",
"url": "https://www.tresiba.com/support-and-resources/videos-and-resources.html",
"headline": "Tresiba® resources",
"description": "Learn about taking Tresiba® (insulin degludec) and how it works by watching videos and downloading educational resources. Read important safety and prescribing info on this page.",
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"item": {
"@id": "https://www.tresiba.com/",
"name": "Homepage"
}
},
{
"@type": "ListItem",
"position": 2,
"item": {
"@id": "https://www.tresiba.com/support-and-resources/videos-and-resources.html",
"name": "Support and Resources"
}
},
{
"@type": "ListItem",
"position": 3,
"item": {
"@id": "https://www.tresiba.com/support-and-resources/videos-and-resources.html",
"name": "Videos and Resources"
}
}
]
},
"about": [
{
"@type": "MedicalCondition",
"name": [
"diabetes"
],
"alternateName": [
"type 1 diabetes",
"type 2 diabetes"
]
},
{
"@type": "MedicalTherapy",
"guideline": [
"Prescription Tresiba® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes"
],
"contraindication": [
"an episode of low blood sugar (hypoglycemia)",
"allergy to Tresiba® or any of the ingredients in Tresiba®"
],
"warning": [
"Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them."
],
"recognizingAuthority": {
"@type": "Organization",
"name": "U.S. Food and Drug Administration",
"alternateName": "FDA",
"url": "https://www.fda.gov/"
}
},
{
"@type": "Drug",
"Name": "Tresiba®",
"nonProprietaryName": "insulin degludec",
"activeIngredient": "insulin degludec",
"alternateName": [
"Tresiba® (insulin aspart) injection 100 Units/mL, 200 Units/mL"
],
"prescriptionStatus": "Available by prescription",
"prescribingInfo": "https://www.novo-pi.com/tresiba.pdf",
"dosageForm": "injection",
"administrationRoute": "injection",
"doseSchedule": [
{
"@type": "DoseSchedule",
"frequency": "once-daily",
"doseUnit": "Units/mL",
"doseValue": [
"100",
"200"
],
"targetPopulation": [
"adults and children who are 1 year of age and older with diabetes"
]
}
],
"offers": {
"@type": "Offer",
"price": "0",
"priceCurrency": "USD",
"url": "https://www.tresiba.com/support-and-resources/videos-and-resources.html"
},
"image": {
"@type": "ImageObject",
"name": "Tresiba® (insulin degludec injection) 100 Units/mL, 200 Units/mL logo",
"contentUrl": "https://www.tresiba.com/content/dam/diabetes/brand/insulin/tresiba/illustrations/Tresiba_U200-U100_Logo_KO.svg"
},
"manufacturer": {
"@type": "Organization",
"name": "Novo Nordisk",
"logo": "https://www.tresiba.com/content/dam/diabetes/brand/insulin/general/novo-nordisk-logo_ko.svg"
}
}
],
"maincontentofpage": [
{
"@type": "WebPageElement",
"headline": "Blood Sugar Tracker",
"text": "Checking your blood sugar every day is an important step in managing your diabetes, as it will help you and your health care provider know if your treatment is working. Learn how to check your blood sugar and track it online through NovoCare®.",
"potentialAction": {
"@type": "Action",
"name": "Download Tracker",
"target": "https://www.tresiba.com/content/dam/diabetes-patient/novocare-diabeteseducation/pdfs/Factsheet_Checking_Your_Blood_Glucose_2024.pdf"
}
},
{
"@type": "WebPageElement",
"headline": "Tresiba® Brochure",
"text": [
"Learn how Tresiba® can help manage blood sugar and may help you reach your A1C goal."
],
"potentialAction": {
"@type": "Action",
"name": "Download brochure",
"target": "https://www.tresiba.com/content/dam/diabetes-patient/tresiba/resources/pdfs/US24TSM00006_TRE_Patient_Brochure_Digital.pdf"
}
},
{
"@type": "WebPageElement",
"headline": "Low Blood Sugar Fact Sheet",
"text": [
"Low blood sugar (hypoglycemia) is something that must be monitored and treated for people with type 1 diabetes. Learn how you can prevent your or your loved one's blood sugar from getting too low and how regular blood sugar checks can help."
],
"potentialAction": {
"@type": "Action",
"name": "Downloadable fact sheet",
"target": "https://diabeteseducation.novocare.com/content/dam/diabetes-patient/novocare-diabeteseducation/pdfs/factsheet_Low_Blood_Glucose.pdf"
}
},
{
"@type": "WebPageElement",
"headline": "We Have Type 1 Diabetes Support for People of all Ages, as Well as for Caregivers",
"text": [
"There are many support options tailored to the needs of people with type 1 diabetes, including children. If you’re in need of information and additional support to help with your or your loved one’s treatment, visit NovoCare.com. There, you will find tips, tricks, and resources including downloadable fact sheets on important information you should know about type 1."
],
"potentialAction": {
"@type": "Action",
"name": "Learn more",
"target": "https://diabeteseducation.novocare.com/for-caregivers.html"
}
}
]
}
🛡️ Trust Signals — external proof links that back the declared identity
0Review mentions (all pages)
0External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /savings.html | 0 | 0 |
| /get-to-know-tresiba/about-tresiba.html | 0 | 0 |
| /support-and-resources/videos-and-resources.html | 0 | 0 |
Explore the other reputation pillars for Tresiba (Novo Nordisk)
Analysis Disclosure & Source Attribution
This page presents a snapshot of public data from Tresiba (Novo Nordisk), captured on June 20, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Tresiba (Novo Nordisk): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://tresiba.com to view the most current version of its content and see directly what this company is about and what it offers.